Platelet rich plasma therapy in patients of leprosy
Not Applicable
Completed
- Conditions
- Health Condition 1: A304- Borderline lepromatous leprosy
- Registration Number
- CTRI/2023/06/054394
- Lead Sponsor
- Shri Ram Murti Smark Institute of Medical and Health Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
Patients attending leprosy clinic
Patients with bilateral palpable thickened nerves
Exclusion Criteria
Patients refusing to participate in the study
Patients not willing to give written informed consent
Patients below 18 yrs and above 50 yrs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet rich plasma shows improvement in nerve conduction and ultrasonographic parameters in neuritis in patients of leprosyTimepoint: Baseline and 4 months
- Secondary Outcome Measures
Name Time Method is the improvement in nerve conduction parameters corresponding to ultrasonographic parametersTimepoint: 4 months